In this Issue
Practical discussions on the growing literature base.
Guest Chief Medical Editors’ Page
By Nadine Abi-Jaoudeh, MD; and Julius Chapiro, MD
A multidisciplinary discussion of the approach to treatment for four patients with cancers of varying origins and severities.
With Ghassan K. Abou-Alfa, MD; Justin D. Blasberg, MD; Frank C. Detterbeck, MD, FACS, FCCP; Dimitris Filippiadis, MD, PhD, EBIR; Ryan Hickey, MD; Howard S. Hochster, MD; Zeljka Jutric, MD; Alexis Kelekis, MD, PhD, EBIR, FSIR; Maureen P. Kohi, MD, FSIR; Alexander Lam, MD; Robert J. Lewandowski, MD, FSIR; Areo Saffarzadeh, MD, MS; Mansi R. Shah, MD; Ronald F. Wolf, MD; Emi J. Yoshida, MD; and Etay Ziv, MD, PhD
Obtaining the highest level of evidence in interventional oncology requires that we stay on course and strive for positive prospective randomized trials.
By Nadine Abi-Jaoudeh, MD
The importance of understanding the levels of evidence related to IO therapies and areas for future research.
By Derek Biederman, MD; and Edward Kim, MD
The current state of evidence for arterial interventions for liver metastases.
By W. Brad Butler, BS; and Daniel B. Brown, MD
Clinical data examining the use of available treatment options for selected lung cancer cases.
By Thierry de Baere, MD
A review of the recently published data that have helped to inform treatment guidelines for renal cell carcinoma.
By Max Padgett, MD; and Kari J. Nelson, MD
Minimally invasive therapies such as embolization, thermal ablation, and consolidative therapy can be used for locoregional control and pain palliation or can be combined for a synergistic effect.
By Steven Yevich, MD, MPH
Experts weigh in on the current roles of various therapeutic options for pancreatic cancer.
With Govindarajan Narayanan, MD; Thomas Scagnelli, MD; Mehul Doshi, MD; Shalini Moningi, MD; Maureen Aliru, BS; Joseph M. Herman, MD, MSc, MSHCH, FACR; Jordan M. Cloyd, MD; Timothy M. Pawlik, MD, MPH, PhD; Mohammad Alasker, MD; and David K. Imagawa, MD, PhD, FACS
Contemporary radioembolization techniques and the approaches to avoid.
By Ahmed Gabr, MD; Robert J. Lewandowski, MD, FSIR; Riad Salem, MD; and Ahsun Riaz, MD
Transarterial embolization techniques for treating liver malignancy are ready for adaptation to prostate cancer applications.
By Raj Ayyagari, MD
Immuno-Oncology and Interventional Oncology: Combining Personalized and Precision Therapies to Enhance Immune Therapies
Using image-guided local treatments to create or augment therapeutic response to molecularly targeted immunogenic drugs.
By Junaid Raja, MD, MSPH, MS; and Hyun S. Kim, MD
How the expanding health care applications of artificial intelligence may be incorporated to improve interventional oncology processes and care.
By Brian Letzen, MD, MS; and Raul N. Uppot, MD
An overview of an interventional radiology training program undertaken in Tanzania by the RAD-AID IR program to establish services in this low-resource setting.
By Fabian Laage Gaupp, MD; and Andrew Kesselman, MD
FEATURED PROGRAMSponsored by Philips
Harmonizing products and services for long-term success.
With Elias Kassab, MD; and Phil Hemstreet, MD
FEATURED TECHNOLOGYSponsored by Medtronic
Use of the MVP™ Micro Vascular Plug System as a Single Occlusion Device to Treat Pulmonary Arteriovenous Malformations
Real-world case reports demonstrating the unique benefits that this system offers to patients and operators.
By Brian Holly, MD; and Sanjeeva Kalva, MD
MEDICAL AFFAIRS CORNERSponsored by MEDTRONIC
By Fabrizio Fanelli, MD, EBIR
Dr. Dabus discusses the rapidly evolving field of neurointerventional stroke care, areas that require further study and efforts, and the path that led him to find his passion for this specialty.